• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vivos Therapeutics, Inc. - Common Stock (NQ:VVOS)

0.1311 -0.0117 (-8.19%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vivos Therapeutics, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports on Q2 Q3 2022 Financial Results, Announces Conference Call
December 16, 2022
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
December 15, 2022
  On Thursday, 241 companies hit new 52-week lows. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Creates Strategic Medical Billing Partnership, New Revenue Stream
December 15, 2022
Via Investor Brand Network
News headline image
Earnings Scheduled For May 16, 2022 ↗
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives NASDAQ Notification Regarding Q3 Quarterly Report Filing
November 29, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Update on Revenue Recognition Review
November 22, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Q2 Earnings Delay
August 23, 2022
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
September 22, 2022
  On Thursday, 1076 companies hit new 52-week lows. 
Via Benzinga
Vivos Announces 4th Annual Breathing Wellness Conference in Cancún, Mexico, With Full Slate of World-Renowned Speakers
August 23, 2022
Vivos Therapeutics, Inc. (NASDAQ: VVOS) ("Vivos") is excited to announce the fourth annual Breathing Wellness Conference, which will take place Oct. 26-29, 2022, at the Hilton Hotel in Cancún, Mexico.... 
Via Newswire.com
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Reschedule Release of Q2 2022 Financial Results
August 15, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Q2 2022 Call to Discuss Financial Results
August 09, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives Regulatory Clearances in Australia for Line of Oral Appliances
July 14, 2022
Via Investor Brand Network
News headline image
Earnings Scheduled For August 15, 2022 ↗
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
August 01, 2022
  On Monday, 92 companies set new 52-week lows. 
Via Benzinga
News headline image
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances
July 14, 2022
From Vivos Therapeutics, Inc.
Via Business Wire
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Presents Sleep Apnea Study Results at Annual SLEEP 2022 Event
June 14, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation in Annual SLEEP 2022 Event
May 26, 2022
Via Investor Brand Network
News headline image
91 Biggest Movers From Friday ↗
June 13, 2022
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. 
Via Benzinga
News headline image
70 Biggest Movers From Friday ↗
May 31, 2022
Gainers Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for... 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q1 2021 Financial, Operational Report
May 17, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q1 2022 Results, Conference Call
April 28, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Opens Third US Multidisciplinary Sleep Apnea Clinic
April 26, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, Full-Year 2021 Financial, Operational Report
April 01, 2022
Via Investor Brand Network
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
April 25, 2022
On Monday, 721 companies achieved new lows for the year. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Call to Review Q4, FY 2021 Financial Results
March 31, 2022
Via Investor Brand Network
News headline image
51 Biggest Movers From Yesterday ↗
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are... 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Selected Among ‘World’s Most Innovative Companies’ by Fast Company Magazine
March 08, 2022
Via Investor Brand Network
News headline image
55 Biggest Movers From Friday ↗
April 04, 2022
Gainers Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday. Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) rose 43.8% to settle at $11.49... 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Rebrands Proprietary Offering of Clinical Treatment Devices, Modalities and Protocols
March 03, 2022
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Plans to Participate in Investor Conferences
March 02, 2022
Via Investor Brand Network
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap